miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism
Xian-ye Tang,1,2,* Wei Zheng,1,2,* Min Ding,3 Kai-jin Guo,1,2 Feng Yuan,1 Hu Feng,1 Bin Deng,1 Wei Sun,1 Yang Hou,4 Lu Gao5,6 1Department of Orthopedic, The First Clinical Medical College, Nanjing Medical University, Nanjing, 2Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu, 3Departme...
Saved in:
Main Authors: | Tang XY (Author), Zheng W (Author), Ding M (Author), Guo KJ (Author), Yuan F (Author), Feng H (Author), Deng B (Author), Sun W (Author), Hou Y (Author), Gao L (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dysregulation of Neuregulin-1/ErbB signaling in the hippocampus of rats after administration of doxorubicin
by: Liao D, et al.
Published: (2018) -
Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer
by: Sho Ueno, et al.
Published: (2020) -
Role of ErbB receptors in cancer cell migration and invasion
by: Aline eAppert-Collin, et al.
Published: (2015) -
Role of C-erbB2 expression in gallbladder cancer
by: Niraj Kumari, et al.
Published: (2012) -
miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1
by: Zhuojia Lin, et al.
Published: (2018)